MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-615

  1. 542 Posts.
    lightbulb Created with Sketch. 124
    Hi dplane thanks for your great posts. But surely if ARDS trial comes thru with approval then AGVHD given its similarity to ARDS has to be given eventual approval?, to me these events are not mutually exclusive
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.